文献速递儿童青少年精神

自闭症谱系障碍患者脑类器官的蛋白质组表型揭示能量代谢、细胞组分与生物过程紊乱

Proteomic phenotype of cerebral organoids derived from autism spectrum disorder patients reveal disrupted energy metabolism, cellular components, and biological processes.
PubMed 文献 · Mol Psychiatry · 2022-05-26

研究利用自闭症谱系障碍(ASD)患者来源的脑类器官,捕捉神经发育关键时间点,检测代谢与蛋白表达。在体外第39天神经发生开始时,ASD类器官较对照组体积增大,且体积与Ki-67阳性增殖细胞数相关;同时能量代谢与蛋白质组表型存在显著差异,表现为糖酵解优于氧化磷酸化、ATP生成与线粒体呼吸链活性降低,以及细胞黏附蛋白、细胞周期、细胞骨架和多个转录因子差异表达。

要点

  • ASD来源脑类器官在体外第39天神经发生开始时呈现体积增大,体积与Ki-67阳性增殖细胞数相关。
  • ASD类器官在该时间点能量代谢显著改变:糖酵解优于氧化磷酸化,ATP生成与线粒体呼吸链活性降低。

研究设计与样本

  • 研究生成ASD患者来源的脑类器官以捕捉神经元发育关键时间点,并检测代谢与蛋白表达。
  • 比较ASD来源类器官与对照类器官在早期发育阶段(体外第39天神经发生开始时)的体积、增殖细胞数与蛋白质组表型。

主要发现

  • 在发育第一个月,ASD来源类器官较对照组体积增大,且类器官大小与Ki-67阳性增殖细胞数相关。
  • ASD类器官在体外第39天能量代谢与蛋白质组表型存在显著差异,表现为糖酵解优于氧化磷酸化、ATP生成降低、线粒体呼吸链活性降低。
  • ASD类器官中细胞黏附蛋白、细胞周期(纺锤体形成)、细胞骨架及若干转录因子差异表达。

关键数值与推荐

  • ASD来源类器官较对照组体积增大,类器官大小与Ki-67阳性增殖细胞数相关。
  • ASD类器官在体外第39天呈现糖酵解优于氧化磷酸化、ATP生成降低、线粒体呼吸链活性降低。

临床怎么用

  • ASD患者来源脑类器官可用于捕捉神经发育关键时间点的代谢与蛋白质组改变,第39天为关键时间点。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The way in which brain morphology and proteome are remodeled during embryonal development, and how they are linked to the cellular metabolism, could be a key for elucidating the pathological mechanisms of certain neurodevelopmental disorders. Cerebral organoids derived from autism spectrum disorder (ASD) patients were generated to capture critical time-points in the neuronal development, and metabolism and protein expression were investigated. The early stages of development, when neurogenesis commences (day in vitro 39), appeared to be a critical timepoint in pathogenesis. In the first month of development, increased size in ASD-derived organoids were detected in comparison to the controls. The size of the organoids correlates with the number of proliferating cells (Ki-67 positive cells). A significant difference in energy metabolism and proteome phenotype was also observed in ASD organoids at this time point, specifically, prevalence of glycolysis over oxidative phosphorylation, decreased ATP production and mitochondrial respiratory chain activity, differently expressed cell adhesion proteins, cell cycle (spindle formation), cytoskeleton, and several transcription factors. Finally, ASD patients and controls derived organoids were clustered based on a differential expression of ten proteins-heat shock protein 27 (hsp27) phospho Ser 15, Pyk (FAK2), Elk-1, Rac1/cdc42, S6 ribosomal protein phospho Ser 240/Ser 244, Ha-ras, mTOR (FRAP) phospho Ser 2448, PKCα, FoxO3a, Src family phospho Tyr 416-at day 39 which could be defined as potential biomarkers and further investigated for potential drug development.

来源:Mol Psychiatry,查看原文。版权归原作者所有。

引用

  1. Ilieva M, Aldana BI, Vinten KT, et al. Proteomic phenotype of cerebral organoids derived from autism spectrum disorder patients reveal disrupted energy metabolism, cellular components, and biological processes. Mol Psychiatry. 2022. PMID: 35618886. doi:10.1038/s41380-022-01627-2

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。